 | Up a level |
Journal Article
Borchmann, Peter, Moccia, Alden, Greil, Richard, Hertzberg, Mark, Schaub, Valdete, Huettmann, Andreas, Keil, Felix, Dierlamm, Judith, Haenel, Mathias, Novak, Urban, Meissner, Julia, Zimmermann, Andreas, Mathas, Stephan, Zijlstra, Josee M., Fossa, Alexander, Viardot, Andreas, Hertenstein, Bernd, Martin, Sonja, Giri, Pratyush, Kamper, Peter, Molin, Daniel, Kreissl, Stefanie, Fuchs, Michael, Schneider, Gundolf, Rosenwald, Andreas, Klapper, Wolfram, Eich, Hans, Baues, Christian, Hallek, Michael, Dietlein, Markus, Kobe, Carsten, Diehl, Volker and Engert, Andreas (2022). Treatment Related Morbidity in Patients with Classical Hodgkin Lymphoma: Results of the Ongoing, Randomized Phase III HD21 Trial By the German Hodgkin Study Group. Blood, 140. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Herbrand, Amanda Katherina, Schmitt, Andreas M., Briel, Matthias 
ORCID: 0000-0002-2070-5230, Ewald, Hannah ORCID: 0000-0002-5081-1093, Goldkuhle, Marius, Diem, Stefan, Hoogkamer, Anouk, Joerger, Markus, Moffa, Giusi ORCID: 0000-0002-2739-0454, Novak, Urban, Hemkens, Lars G. and Kasenda, Benjamin ORCID: 0000-0003-0110-8585
(2021).
Association of Supporting Trial Evidence and Reimbursement for Off-Label Use of Cancer Drugs.
JAMA Netw. Open, 4 (3).
CHICAGO:
AMER MEDICAL ASSOC.
ISSN 2574-3805